IKARIAN CAPITAL
IKARIAN CAPITAL, LLC Legal Name
Adviser information for IKARIAN CAPITAL last updated from Form ADV on March 28th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Liability Company |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 7 |
---|---|
Investment Advisory/Research | 5 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 5 | $565.2M |
Non-Discretionary | 0 | $0 |
Total | 5 | $565.2M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 5 | $565.2M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 60 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Other Business Activities | Commodity pool operator or commodity trading advisor |
Principal Office
100 CRESCENT COURTSUITE 1620
DALLAS
TX
United States
Monday - Friday, 9AM-5PM
Tel: 214-276-0670, Fax: None
Chief Compliance Officer
TROY WUERTZ
CHIEF OPERATING OFFICER AND GENERAL COUNSEL
100 CRESCENT COURT
SUITE 1620
DALLAS
TX
United States
Tel:
214-276-0670
T***@*****************M
(Full email address available in API data)
Industry Affiliates
IKARIAN HEALTHCARE FUND GP, L.P. | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
IKARIAN HEALTHCARE MASTER FUND, L.P. | Hedge Fund | $473.1M | $1.0M | 155 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
CHART WESTCOTT LIVING TRUST | Domestic Entity | – | MEMBER | 03/2015 | 50-75% |
SHAHRESTANI, NEIL, TRISTAN | Individual | – | CHIEF EXECUTIVE OFFICER/MANAGER | 03/2015 | < 5% |
WESTCOTT, CHART | Individual | CHART WESTCOTT LIVING TRUST | TRUSTEE | 03/2015 | |
WUERTZ, TROY, DAVID | Individual | – | CCO/ COO/ GENERAL COUNSEL | 02/2021 | < 5% |
NK CAPRI, LP | Domestic Entity | – | MEMBER | 05/2020 | 50-75% |
SHAHRESTANI, NEIL, TRISTAN | Individual | NEIL SHAHRESTANI AND KATLYN SHAHRESTANI CO-TRUSTEES OR THEIR SUCCESSORS IN TRUST OF THE NEIL AND KATLYN SHAHRESTANI LIVING TRUST | CO-TRUSTEE | 03/2020 | |
NEIL SHAHRESTANI AND KATLYN SHAHRESTANI CO-TRUSTEES OR THEIR SUCCESSORS IN TRUST OF THE NEIL AND KATLYN SHAHRESTANI LIVING TRUST | Domestic Entity | NK CAPRI, LP | LIMITED PARTNER | 04/2020 | > 75% |
SHAHRESTANI, KATLYN, GRACE | Individual | NEIL SHAHRESTANI AND KATLYN SHAHRESTANI CO-TRUSTEES OR THEIR SUCCESSORS IN TRUST OF THE NEIL AND KATLYN SHAHRESTANI LIVING TRUST | CO-TRUSTEE | 03/2020 | |
NK CAPRI GP, LLC | Domestic Entity | NK CAPRI, LP | GENERAL PARTNER | 04/2020 | |
SHAHRESTANI, NEIL, TRISTAN | Individual | NK CAPRI GP, LLC | MANAGER | 04/2020 | |
SHAHRESTANI, KATLYN, GRACE | Individual | NK CAPRI GP, LLC | MANAGER | 04/2020 | |
KHANNA, VIKRAM | Individual | – | CHIEF INVESTMENT OFFICER | 04/2022 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ABEONA THERAPEUTICS INC | COM NEW | 73K | 171 | – |
ABEONA THERAPEUTICS INC | COM NEW | 3M | 769K | – |
ACELYRIN INC | COM | 7M | 1M | – |
ACHILLES THERAPEUTICS PLC | SPONSORED ADS | 1M | 1M | – |
ACUMEN PHARMACEUTICALS INC | COM | 645K | 266K | – |
AEON BIOPHARMA INC | CL A | 271K | 258K | – |
AEROVATE THERAPEUTICS INC | COM | 166K | 1K | – |
AEROVATE THERAPEUTICS INC | COM | 611K | 368K | – |
ALEXANDRIA REAL ESTATE EQ IN | COM | 9M | 733 | – |
ALLAKOS INC | COM | 973K | 973K | – |
ALNYLAM PHARMACEUTICALS INC | COM | 36M | 2K | – |
ALNYLAM PHARMACEUTICALS INC | COM | 36M | 2K | – |
AMGEN INC | COM | 11M | 350 | – |
AMGEN INC | COM | 8M | 250 | – |
AMGEN INC | COM | 12M | 38K | – |
AMYLYX PHARMACEUTICALS INC | COM | 522K | 275K | – |
ANEBULO PHARMACEUTICALS INC | COM | 431K | 158K | – |
ANNEXON INC | COM | 2M | 380K | – |
ANNOVIS BIO INC | COM | 291K | 506 | – |
ANNOVIS BIO INC | COM | 6K | 11 | – |
ANNOVIS BIO INC | COM | 2M | 3K | – |
ANNOVIS BIO INC | COM | 6K | 11 | – |
ANNOVIS BIO INC | COM | 1M | 3K | – |
ARCUS BIOSCIENCES INC | COM | 2M | 145K | – |
ARCUTIS BIOTHERAPEUTICS INC | COM | 5M | 490K | – |
ASTRAZENECA PLC | SPONSORED ADR | 9M | 1K | – |
AVALO THERAPEUTICS INC | COM NEW | 682K | 55K | – |
BRAINSTORM CELL THERAPEUTICS | COM NEW | 31K | 90K | – |
BRIDGEBIO PHARMA INC | COM | 10M | 4K | – |
BRIDGEBIO PHARMA INC | COM | 5M | 2K | – |
BRIDGEBIO PHARMA INC | COM | 8M | 332K | – |
CARTESIAN THERAPEUTICS INC | COM NEW | 7M | 242K | – |
CATALYST PHARMACEUTICALS INC | COM | 8M | 518K | – |
CERVOMED INC | COM | 4M | 237K | – |
CHEMOMAB THERAPEUTICS LTD | SPONSORED ADS | 196K | 213K | – |
COMPASS PATHWAYS PLC | SPONSORED ADS | 2M | 303K | – |
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 14M | 310K | – |
CORCEPT THERAPEUTICS INC | COM | 6M | 2K | – |
CRINETICS PHARMACEUTICALS IN | COM | 26M | 589K | – |
CYBIN INC | COM | 4M | 14M | – |
CYTOKINETICS INC | COM NEW | 9M | 170K | – |
CYTOMX THERAPEUTICS INC | COM | 11K | 9K | – |
DELCATH SYS INC | COM NEW | 840K | 100K | – |
ELEVATION ONCOLOGY INC | COM | 2M | 690K | – |
ELIEM THERAPEUTICS INC | COM | 711K | 100K | – |
ENLIVEN THERAPEUTICS INC | COM | 14M | 587K | – |
G1 THERAPEUTICS INC | COM | 2M | 10K | – |
G1 THERAPEUTICS INC | COM | 513K | 2K | – |
G1 THERAPEUTICS INC | COM | 513K | 2K | – |
G1 THERAPEUTICS INC | COM | 140K | 616 | – |
G1 THERAPEUTICS INC | COM | 2M | 10K | – |
IBIO INC | CON NEW | 1M | 600K | – |
IMMATICS N.V | SHS | 574K | 49K | – |
IMMUNIC INC | COM | 548K | 493K | – |
IMMUNOVANT INC | COM | 3M | 1K | – |
IMMUNOVANT INC | COM | 7M | 277K | – |
INFLARX NV | COM | 1M | 705K | – |
INHIBRX BIOSCIENCES INC | COM | 3M | 230K | – |
INSMED INC | COM PAR $.01 | 13K | 2 | – |
INSMED INC | COM PAR $.01 | 14M | 2K | – |
INSMED INC | COM PAR $.01 | 2M | 281 | – |
INSMED INC | COM PAR $.01 | 5M | 694 | – |
INSMED INC | COM PAR $.01 | 13M | 2K | – |
INSMED INC | COM PAR $.01 | 5M | 709 | – |
INSMED INC | COM PAR $.01 | 3M | 48K | – |
ITEOS THERAPEUTICS INC | COM | 1M | 79K | – |
JASPER THERAPEUTICS INC | COM NEW | 2M | 105K | – |
KARYOPHARM THERAPEUTICS INC | COM | 355K | 409K | – |
KEZAR LIFE SCIENCES INC | COM | 521K | 869K | – |
KODIAK SCIENCES INC | COM | 1M | 477K | – |
LARIMAR THERAPEUTICS INC | COM | 2M | 324K | – |
LENZ THERAPEUTICS INC | COM | 4M | 205K | – |
LYELL IMMUNOPHARMA INC | COM | 763K | 526K | – |
LYRA THERAPEUTICS INC | COM | 292K | 1M | – |
MACROGENICS INC | COM | 850K | 200K | – |
MARINUS PHARMACEUTICALS INC | COM NEW | 826K | 706K | – |
MILESTONE PHARMACEUTICALS IN | COM | 620K | 466K | – |
MIND MEDICINE MINDMED INC | COM NEW | 1M | 162K | – |
NEKTAR THERAPEUTICS | COM | 2M | 1M | – |
NEUROCRINE BIOSCIENCES INC | COM | 14M | 1K | – |
NEUROCRINE BIOSCIENCES INC | COM | 6M | 40K | – |
NURIX THERAPEUTICS INC | COM | 9M | 441K | – |
NUVALENT INC | COM | 12M | 152K | – |
NUVATION BIO INC | COM CL A | 1M | 358K | – |
NYXOAH S A | SHS | 357K | 51K | – |
PRAXIS PRECISION MEDICINES I | COM NEW | 4M | 1K | – |
PRAXIS PRECISION MEDICINES I | COM NEW | 8M | 2K | – |
PRAXIS PRECISION MEDICINES I | COM NEW | 4M | 1K | – |
PRAXIS PRECISION MEDICINES I | COM NEW | 13M | 3K | – |
PROQR THRAPEUTICS N V | SHS EURO | 803K | 484K | – |
PROTARA THERAPEUTICS INC | COM STK | 376K | 181K | – |
PYXIS ONCOLOGY INC | COMMON STOCK | 856K | 3K | – |
PYXIS ONCOLOGY INC | COMMON STOCK | 331K | 1K | – |
PYXIS ONCOLOGY INC | COMMON STOCK | 6M | 2M | – |
Q32 BIO INC | COM | 2M | 109K | – |
RAPT THERAPEUTICS INC | COM | 610K | 2K | – |
RAPT THERAPEUTICS INC | COM | 472K | 155K | – |
RELMADA THERAPEUTICS INC | COM | 121K | 40K | – |
REZOLUTE INC | COM NEW | 4M | 904K | – |
ROCKET PHARMACEUTICALS INC | COM | 4M | 197K | – |
ROIVANT SCIENCES LTD | SHS | 1M | 101K | – |
SAGIMET BIOSCIENCES INC | COM SER A | 1M | 413K | – |
SANA BIOTECHNOLOGY INC | COM | 2M | 4K | – |
SANA BIOTECHNOLOGY INC | COM | 2M | 4K | – |
SAREPTA THERAPEUTICS INC | COM | 16M | 1K | – |
SAREPTA THERAPEUTICS INC | COM | 32M | 204K | – |
SCHOLAR ROCK HLDG CORP | COM | 2M | 184K | – |
SENSEI BIOTHERAPEUTICS INC | COM | 403K | 650K | – |
SILENCE THERAPEUTICS PLC | ADS | 3M | 507K | – |
SOLENO THERAPEUTICS INC | COM | 18M | 445K | – |
STOKE THERAPEUTICS INC | COM | 92K | 7K | – |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 79K | 20 | – |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 1M | 270 | – |
STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 1M | 290 | – |
SYNLOGIC INC | COM NEW | 31K | 20K | – |
TARSUS PHARMACEUTICALS INC | COM | 22M | 800K | – |
TECTONIC THERAPEUTIC INC | COM | 1M | 63K | – |
TEMPEST THERAPEUTICS INC | COM | 231K | 106K | – |
TERNS PHARMACEUTICALS INC | COM | 3M | 458K | – |
TOURMALINE BIO INC | COM | 1M | 108K | – |
VENTYX BIOSCIENCES INC | COM | 1M | 443K | – |
VERONA PHARMA PLC | SPONSORED ADS | 3M | 201K | – |
VERU INC | COM | 796K | 946K | – |
VIKING THERAPEUTICS INC | COM | 7M | 138K | – |
VIRIDIAN THERAPEUTICS INC | COM | 1M | 1K | – |
VIRIDIAN THERAPEUTICS INC | COM | 1M | 1K | – |
VIRIDIAN THERAPEUTICS INC | COM | 2M | 2K | – |
VOYAGER THERAPEUTICS INC | COM | 442K | 56K | – |
WAVE LIFE SCIENCES LTD | SHS | 3M | 575K | – |
XENON PHARMACEUTICALS INC | COM | 4M | 107K | – |